|
03/09/2008
MURs and Bullying: The RPSGB View RPSGB's Professional Services Directorate With news that some pharmacists are being pressurised to perform more medicines use reviews, the RPSGB’s Professional Services Directorate examines the use of targets in delivering the service.
Despite a slow start and some concerns having been expressed about the quality of some initial MURs, there are now encouraging signs that pharmacists are actively engaged in providing this important service. Pharmacists should be looking at the content of the services they deliver to patients, and seeking to adopt best practice.
While there are important and legitimate drivers to increase the number of MURs, there are also reports some pharmacists feel the approach taken by their employers to reach specific volume targets amounts to 'harassing techniques' and 'corporate bullying'. Pharmacists must not be pressurised to achieve targets, especially if they feel the achievement of the targets would compromise patient care. The role of targets
While targets can be set, it is however important they do not replace an individual's professional judgement and autonomy in deciding when, for example, an MUR might be appropriate.1 It is up to the individual pharmacist to decide which patients receive this service, although local PCOs or GPs may recommend specific groups of patients that may be appropriate for targeting.
The provision of MURs does form part of the community pharmacy contract and therefore there is an obligation on NHS pharmacy contractors to provide this service to patients. As a pharmacist you should not refuse to undertake MURs unless there are valid reasons such as workload pressures or a negative impact on patient safety.
If, however, a pharmacist has been set targets they believe are unachievable they should in the first instance raise their concerns with their line manager. If you don't report your concerns, it is difficult for the person in a position of authority to respond to them. There should be a two-way communication between the pharmacist and employer to discuss any concerns that either may have. Reconfiguration or prioritisation of work flow, alternative or additional staffing or other ways of working could be considered as part of this.
Target-setting
Thus, if targets are to be set, it is important that they take account of the complexities of the situation, and also take account of the wider services and workload of the pharmacy.
Supporting pharmacists
Pharmacists may require support in terms of how to conduct an MUR effectively and efficiently, how to find time to conduct MURs, in targeting patients who would benefit from an MUR, and in effective delegation of certain tasks to other staff. The Society's English and Welsh pharmacy boards will be working with other professional organisations to address a number of these issues.
As the role of the pharmacist evolves to having a more clinical focus, it is important to remember that times of change can be stressful for individuals. Employers should be alert to signs of stress, and support pharmacists through the period of change.
Responsibility for safety
Support from the Society
The Society is currently developing an MUR multidisciplinary audit tool that will demonstrate the benefit and quality of MURs. The audit aims to help pharmacists measure the quality of the MURs undertaken; it is planned for this to be available from spring 2009. The audit toolkit will help to demonstrate the benefit of MURs and in so doing help commissioners to understand them.
If you have concerns about any breaches of the requirements of the Code of Ethics, you can contact the legal and ethical advisory service (email: leadvice@rpsgb.org or tel: 0207 572 2308), or you can make a formal complaint to the Society's fitness to practise and legal affairs directorate.
References
|
RELATED ARTICLES MUR tip of the week: Secondary prevention of stroke or TIA > Regulatory watchdog to review RPSGB complaints efficiency > The Co-operative Pharmacy urges fasting Muslims to quit smoking during Ramadan > Pharmacy an “under-used asset”, says Lansley in Number 10 web chat > MUR Tip of the week: carbimazole > RPSGB announces consultation into remote supervision > RPSGB responds to enquiry and excellence: liberating the nhs > MUR Tip of the week: beta-blockers > PCTs tell Yorkshire pharmacists to dispense clopidogrel off licence > Pharmacy bodies target united front as white paper transforms NHS > |
|||